Federal Register / Vol. 66, No. 241 / Friday, December 14, 2001 / Notices 64841

comment stated that clarification is

needed as to whether Medication

Guides would be needed for medical

devices that have a prescription drug

either as a coating or incorporated into

the material of the device, or as a

component in a kit. The comment said

that some of these types of products

might be considered combination

products.

FDA requested comments on the

information collection burden estimates

described in the notice. Because the

comment does not pertain to the burden

estimates, FDA has forwarded the

comment to Docket Number 93N–0371,

‘‘Prescription Drug Product Labeling;

Medication Guide Requirements.’’ FDA

appreciates the comment and will

consider it as part of its Medication

Guide program.

Dated: December 7, 2001.

Margaret M. Dotzel,

Associate Commissioner for Policy.

[FR Doc. 01–30852 Filed 12–13–01; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Special Emphasis, Panel.

Date: January 6–8, 2002.

Time: 7 p.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

Place: Hotel Wales, 1295 Madison Avenue,

New York, NY 10128.

Contact Person: Francisco O. Calvo, PhD,

Chief, Review Branch, DEA, NIDDK, Room

752, 6707 Democracy Boulevard, National

Institutes of Health, Bethesda, MD 20892–

6600, (301) 594–8897.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.847, Diabetes,

Endocrinology and Metabolic Research;

93.848, Digestive Diseases and Nutrition

Research; 93.849, Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health, HHS)

Dated: December 5, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–30874 Filed 12–13–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Deafness and

Other Communications Disorders;

Notice of Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

National Deafness and Other

Communications Disorders Advisory

Council.

The meeting will be open to the

public as indicated below, with

attendance limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the Contact Person listed below

in advance of the meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

discussions could disclose confidential

trade secrets or commercial property

such as patentable material, and

personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Deafness and

Other Communication Disorders Advisory

Council.

Date: January 18, 2002.

Open: 8:30 a.m. to 11:15 a.m.

Agenda: Staff reports on divisional,

programmatic, and special activities.

Place: 31 Center Drive, Bldg. 31, Conf. Rm.

6, Bethesda, MD 20892.

Closed: 11:15 a.m. to Adjournment.

Agenda: To review and evaluate grant

applications.

Place: 31 Center Drive, Bldg. 31, Conf. Rm.

6, Bethesda, MD 20892.

Contact Person: Craig A. Jordan, PhD,

Chief, Scientific Review Branch, NIH/

NIDCD/DER, Executive Plaza South, Room

400C, Bethesda, MD 20892–7180, 301–496–

8683.

In the interest of security, NIH has

instituted stringent procedures for entrance

into the building by non-government

employees. Persons without a government

I.D. will need to show a photo I.D. and signin at the security desk upon entering the

building.

Information is also available on the

Institute’s/Center’s home page:

www.nidcd.nih.gov/about/councils/ndcdac/

ndcdac.htm, where an agenda and any

additional information for the meeting will

be posted when available.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.173, Biological Research

Related to Deafness and Communicative

Disorders, National Institutes of Health, HHS)

Dated: December 5, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–30875 Filed 12–13–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Child Health and

Human Development; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Child Health and Human Development

Special Emphasis Panel, Mental Retardation

and Developmental Disabilities.

Date: December 10, 2001.

Time: 11 a.m. to 12 p.m.

Agenda: To review and evaluate grant

applications.

Place: 6100 Executive Blvd., Room 5E01,

Rockville, MD 20852 (Telephone Conference

Call).

Contact Person: Norman Chang, PhD,

Scientific Review Administrator, Division of

Scientific Review, National Institute of Child

Health and Human Development, National

Institute of Health, 6100 Executive Blvd.,

Room 5E03, Bethesda, MD 20892, (301) 496–

1485.

This notice is being published less than 15

days prior to the meeting due to the timing